💻 Technology · Next Week

Apple unveils a new Apple Watch generation with enhanced health tracking at the September 2026 event (9 September, Apple Park, confirmed by Apple press release or apple.com)

Hit ✦ AI-generated prediction Published on 30. August 2026 · Predicted for 9. September 2026 · Based on: Historical Cycle

Probability

83%

Apple's September 2026 event is officially confirmed for 9 September under the theme 'Surprise and Shine' at Apple Park (MacRumors, 26.08.2026). Apple has introduced a new Apple Watch generation at every September event since 2015 — an exception would be historically unique. Alongside the iPhone 18 Pro and foldable iPhone Ultra (A20 Pro chip), the new Apple Watch (Series 12 or new naming) with the long-awaited blood pressure monitoring health upgrade has been planned since 2025 (per MacRumors/Digital Trends). Probability is very high — Apple never closes its fall lineup without Apple Watch.

Data basis for this prediction

MacRumors: Apple September Event 2026 bestätigt, 9. Sept., 'Surprise and Shine' (26.08.2026)
Digital Trends: iPhone 18 Pro/Ultra Event Details inkl. A20-Pro-Chip (Aug 2026)
Apple Watch Tradition: neue Generation bei jedem September-Event seit 2015 (apple.com, historisch)

Verdict: Hit

Die Vorhersage ist eingetreten. Apple hielt das September-Event am 9. September 2026 unter dem Motto 'Surprise and Shine' im Apple Park ab und stellte die Apple Watch Series 12 mit dem neuen S11-Chip und einem deutlich erweiterten Health-Tracking-System vor: Herzfrequenzmessung alle 5 Sekunden (60x häufiger als zuvor), neue 'Readiness'-Funktion, HRV-Messung alle 5 Minuten und eine neue 'Health Age'-Funktion. Dies wurde u.a. auf MacRumors (macrumors.com/2026/09/09/apple-watch-series-12-announced-all-day-hr-sensor/) und 9to5Mac (9to5mac.com/2026/09/09/apple-watch-series-12-and-ultra-4-unveiled-with-upgraded-health-tracking-system/) bestätigt. Einschränkung: Das in der Vorhersagebegründung erwähnte Blutdruck-Feature war bereits 2025 mit der Apple Watch Series 11 eingeführt worden – die Series 12 brachte andere, neue Health-Upgrades. Der Kern der Vorhersage (neue Apple Watch-Generation mit erweitertem Health-Tracking am 9. September 2026) ist jedoch vollständig bestätigt.

Related Predictions

💻 Technology ✦ AI

Applied Materials Inc. (NASDAQ: AMAT) beats Q4 FY2026 EPS consensus of $4.06 per share — earnings report November 12, 2026 after market close (confirmed by Applied Materials Investor Relations or Bloomberg by November 13, 2026, 10:00 AM ET)

Applied Materials has beaten the EPS consensus in all four of its last reported quarters, with an average earnings surprise of +3.5%. The company's own Q4 guidance is $3.82–$4.22 per share; consensus at $4.06 sits near the midpoint, reflecting classic conservative management framing. Revenue is estimated at $10.30B (+51% YoY) — TSMC and Samsung have not pulled back H2 2026 capex plans. No Polymarket market directly available; a 100% beat streak over 4 quarters with a positive guidance range implies 70–75% probability. Risk: supply chain delays or expanded US export controls on advanced chips could force a Q5 inventory build.

72%

Next Week · Predicted for 12. Nov 2026

💻 Technology ✦ AI

Palantir Technologies Inc. (NYSE: PLTR) closes above $185.00 per share on at least one trading day in November 2026 — confirmed by Nasdaq or Bloomberg by December 1, 2026

PLTR closed at $175.40 on November 4, 2026 (after-hours: $170.88, -2.58%; intraday high: $176.54; 52-week high: $212.94). Palantir clearly beat Q3-FY2026 EPS consensus: total revenue $2.313B, US Commercial revenue +148% YoY to $984M. The $185 threshold is +5.5% above the closing price or +8.3% above after-hours levels. Typical post-earnings 'sell the news' may weigh short-term, but the 52-week high of $212.94 confirms the level is reachable. NVIDIA earnings on November 18, 2026 could serve as a sector-wide catalyst. No direct Polymarket equivalent; own estimate: ~42%.

42%

Next Month · Predicted for 30. Nov 2026

💻 Technology ✦ AI

Cerebras Systems (NASDAQ: CBRS) closes below $100.00 per share on November 10, 2026 (confirmed by Nasdaq or Bloomberg by November 11, 2026)

CBRS trades at $109.18 (October 30, 2026) — already 61% below its all-time high of $279.72. The final and largest lockup expiration is scheduled for November 10, 2026: approximately 19.4 million shares are unlocked (of three tranches of 19.4M each). Prior lockup tranches have consistently weighed on the stock. Insiders have sold ~$394.6M in shares since the May 2026 IPO — zero insider purchases. A Culper Research short-seller report has triggered multiple investigations. A close below $100 requires a ~8.4% decline — plausible given the expected supply pressure on expiration day.

62%

Next Week · Predicted for 10. Nov 2026